95 related articles for article (PubMed ID: 30928412)
1. Neutral sphingomyelinase increases and delocalizes in the absence of Toll-Like Receptor 4: A new insight for MPTP neurotoxicity.
Albi E; Cataldi S; Codini M; Mariucci G; Lazzarini A; Ceccarini MR; Ferri I; Laurenti ME; Arcuri C; Patria F; Beccari T; Conte C
Prostaglandins Other Lipid Mediat; 2019 Jun; 142():46-52. PubMed ID: 30928412
[TBL] [Abstract][Full Text] [Related]
2. Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells.
Cataldi S; Arcuri C; Hunot S; Légeron FP; Mecca C; Garcia-Gil M; Lazzarini A; Codini M; Beccari T; Tasegian A; Fioretti B; Traina G; Ambesi-Impiombato FS; Curcio F; Albi E
Mediators Inflamm; 2017; 2017():2470950. PubMed ID: 29343884
[TBL] [Abstract][Full Text] [Related]
3. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
Mariucci G; Pagiotti R; Galli F; Romani L; Conte C
J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
[TBL] [Abstract][Full Text] [Related]
4. Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.
Conte C; Roscini L; Sardella R; Mariucci G; Scorzoni S; Beccari T; Corte L
Neurochem Res; 2017 Feb; 42(2):493-500. PubMed ID: 28108849
[TBL] [Abstract][Full Text] [Related]
5. Niemann-Pick Type A Disease: Behavior of Neutral Sphingomyelinase and Vitamin D Receptor.
Conte C; Arcuri C; Cataldi S; Mecca C; Codini M; Ceccarini MR; Patria FF; Beccari T; Albi E
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31086057
[TBL] [Abstract][Full Text] [Related]
6. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
Watanabe M; Kitano T; Kondo T; Yabu T; Taguchi Y; Tashima M; Umehara H; Domae N; Uchiyama T; Okazaki T
Cancer Res; 2004 Feb; 64(3):1000-7. PubMed ID: 14871831
[TBL] [Abstract][Full Text] [Related]
7. Interfacial regulation of bacterial sphingomyelinase activity.
Jungner M; Ohvo H; Slotte JP
Biochim Biophys Acta; 1997 Feb; 1344(3):230-40. PubMed ID: 9059513
[TBL] [Abstract][Full Text] [Related]
8. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
Ookubo M; Yokoyama H; Kato H; Araki T
Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
[TBL] [Abstract][Full Text] [Related]
9. Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.
Wang L; Zhai YQ; Xu LL; Qiao C; Sun XL; Ding JH; Lu M; Hu G
Exp Neurol; 2014 Jan; 251():22-9. PubMed ID: 24220636
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic activity and immunolocalization of Schistosoma mansoni and Schistosoma haematobium neutral sphingomyelinase.
Tallima H; Al-Halbosiy MF; El Ridi R
Mol Biochem Parasitol; 2011; 178(1-2):23-8. PubMed ID: 21524668
[TBL] [Abstract][Full Text] [Related]
11. TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease.
Zhao XD; Wang FX; Cao WF; Zhang YH; Li Y
Int Immunopharmacol; 2016 Mar; 32():96-102. PubMed ID: 26803521
[TBL] [Abstract][Full Text] [Related]
12. Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide.
Lin M; Liao W; Dong M; Zhu R; Xiao J; Sun T; Chen Z; Wu B; Jin J
FEBS J; 2018 Oct; 285(20):3835-3848. PubMed ID: 30106227
[TBL] [Abstract][Full Text] [Related]
13. Effect of manganese exposure on MPTP neurotoxicities.
Baek SY; Lee MJ; Jung HS; Kim HJ; Lee CR; Yoo C; Lee JH; Lee H; Yoon CS; Kim YH; Park J; Kim JW; Jeon BS; Kim Y
Neurotoxicology; 2003 Aug; 24(4-5):657-65. PubMed ID: 12900079
[TBL] [Abstract][Full Text] [Related]
14. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
15. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
[TBL] [Abstract][Full Text] [Related]
16. Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide.
Yang DI; Yeh CH; Chen S; Xu J; Hsu CY
Neurobiol Dis; 2004 Oct; 17(1):99-107. PubMed ID: 15350970
[TBL] [Abstract][Full Text] [Related]
17. Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice. Are the striatal astrocytes regionally activated after systemic MPTP administration?
Chen LW; Wei LC; Qiu Y; Liu HL; Rao ZR; Ju G; Chan YS
Brain Res; 2002 Jan; 925(1):9-17. PubMed ID: 11755896
[TBL] [Abstract][Full Text] [Related]
18. Rapid replenishment of sphingomyelin in the plasma membrane upon degradation by sphingomyelinase in NIH3T3 cells overexpressing the phosphatidylinositol transfer protein beta.
Van Tiel CM; Luberto C; Snoek GT; Hannun YA; Wirtz KW
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):537-43. PubMed ID: 10677376
[TBL] [Abstract][Full Text] [Related]
19. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.
Ito T; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):121-5. PubMed ID: 21788124
[TBL] [Abstract][Full Text] [Related]
20. Acid sphingomyelinase is required for lipid Raft TLR4 complex formation.
Cuschieri J; Bulger E; Billgrin J; Garcia I; Maier RV
Surg Infect (Larchmt); 2007 Feb; 8(1):91-106. PubMed ID: 17381401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
